502482-34-0 Usage
Uses
Used in Pharmaceutical Industry:
(S)-1-benzyl-3-tert-butylpiperazine is used as a precursor in the synthesis of various drugs, particularly those targeting the central nervous system. Its unique structure allows for the development of compounds with potential therapeutic effects on neurological disorders.
Used in Medicinal Chemistry and Drug Discovery:
(S)-1-benzyl-3-tert-butylpiperazine serves as a potential ligand in medicinal chemistry and drug discovery due to its ability to interact with specific biological targets. This interaction can lead to the development of new drugs with improved efficacy and selectivity.
Used in the Treatment of Neurological Disorders:
(S)-1-benzyl-3-tert-butylpiperazine has been studied for its potential therapeutic applications in the treatment of neurological disorders. Its unique chemical structure and interaction with biological targets make it a promising candidate for the development of novel treatments for such conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 502482-34-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,0,2,4,8 and 2 respectively; the second part has 2 digits, 3 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 502482-34:
(8*5)+(7*0)+(6*2)+(5*4)+(4*8)+(3*2)+(2*3)+(1*4)=120
120 % 10 = 0
So 502482-34-0 is a valid CAS Registry Number.
502482-34-0Relevant academic research and scientific papers
17 Beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
-
Page 17-18, (2008/06/13)
In its many embodiments, the present invention provides a novel class of compounds as inhibitors of type 3 17β-hydroxysteroid dehydrogenase, methods of preparing such compounds, pharmaceutical compositions containing one or more such compounds, methods of
17-Beta hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
-
Page 17, (2010/02/05)
There are disclosed compounds of the formula (I): prodrugs thereof, or pharmaceutically acceptable salts of the compounds or of said prodrugs which are useful as inhibitors of Type 3 17β-Hydroxysteroid Dehydrogenase. Also disclosed are pharmaceutical compositions containing said compounds and their use for the treatment or prevention of androgen dependent diseases.
